Maximilian Mair

Medical University of Vienna

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (30)

Collaborators (11)

Martin van den Bent

Erasmus University Rotterdam

Timothy Kaufmann

Associate Professor

Mayo Clinic Minnesota

UNITED STATES

Hui K. Gan

La Trobe University

Michele Ceccarelli

University of Miami

UNITED STATES

Thomas Roetzer-Pejrimovsky

Medical University of Vienna

Benjamin M Ellingson

University of California, Los Angeles

UNITED STATES

Christoph Minichsdorfer

Luzia Berchtold

Medical University of Vienna

Michael Weller

University Hospital of Zurich

Michele Maio

Andrea Anichini

Fondazione IRCCS Istituto Nazionale dei Tumori

Maximilian Mair

Research Interests

Explore related searches

Contact this professor

Articles (30)

Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas

Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey

Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey

The Presence of Neutrophil Extracellular Traps (NETs) in Brain Tumor Vessels Is Linked to Platelet Aggregates and Podoplanin in the Tumor Microenvironment

Author Correction: RANO criteria for response assessment of brain metastases based on amino acid PET imaging

RANO criteria for response assessment of brain metastases based on amino acid PET imaging (vol 31, pg 1424, 2025)

RANO criteria for response assessment of brain metastases based on amino acid PET imaging

Geschlechtssensibles FET-PET? Eine retrospektive Untersuchung geschlechtsspezifischer Unterschiede des FET-Uptakes in der Gliombildgebung

Prognostic impact of amino acid PET parameters in IDH-mutant gliomas diagnosed according to the WHO 2021 Classification of CNS Tumors

Uptake patterns of PSMA PET in brain tumors: comparative analysis of [68Ga]Ga-PSMA-11 or [18F]PSMA-1007 PET with [18F]FET PET and contrast-enhanced MRI

1823P Significance of skeletal muscle measurement in cancer-associated cachexia screening

1895P Higher modified Glasgow Prognostic Score in cancer patients at the Emergency Department is associated with an increased risk of hospital admissions

450MO Characterization of tumor-infiltrating lymphocytes and tumor-associated macrophages within the tumor microenvironment of primary tumors and matched brain metastases

Translating the theranostic concept to neuro-oncology: disrupting barriers

FINAL outcome ANALYSIS FROM THE PHASE II TUXEDO-1 TRIAL OF TRASTUZUMAB-DERUXTECAN IN HER2-positive breast cancer PATIENTS WITH active brain metastases

Radioligand therapies in meningioma – evidence and future directions

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group

Complication Rates of Peripherally Inserted Central Catheters in Oncologic Versus Non-Oncologic Patients

ESMO 2022: spotlight on new emerging treatment options in central nervous system tumors

Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial

Immunotherapy for brain metastases and primary brain tumors

Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042

Cellular and humoral responses to fourth SARS-CoV-2 vaccination in a real-life cohort of patients with cancer

Career and Professional Development for Young Oncologists

CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT

Emerging systemic treatment options in meningioma

Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer

P11.27.B Whole genome DNA methylation as predictive biomarker in CNS WHO grade 2 and 3 oligodendroglioma patients receiving early postoperative treatment

Collaborators (11)

Martin van den Bent

Timothy Kaufmann

Hui K. Gan

Michele Ceccarelli

Thomas Roetzer-Pejrimovsky

Benjamin M Ellingson

Christoph Minichsdorfer

Luzia Berchtold

Michael Weller

Michele Maio

Andrea Anichini

How do I reach out?

Meet Kite AI